3rd Risk-Based Quality Management Summit

The clinical trial landscape has shifted as a result of COVID-19 and quality risk management techniques and tools have evolved by leaps and bounds over the last year. Best practices in RBQM are influencing clinical study methodology and decentralized trials, putting a spotlight on risk based data review including site and central monitoring.

One of the challenges of harnessing RBQM to its fullest potential lies in the opportunity to remove silos and work toward more integrated solutions and processes. DGE invites you to attend the 3rd Annual RBQM Summit and hear from industry experts about the details of implementing data flow process maps, audit trails, data monitoring tools and a deep dive into quality tolerance limits.

Featured Topics and Discussions

Cultivate a “culture of quality” and ensure end-to-end RBQM
Expand monitoring to include remote data monitoring, site and central monitoring
Sharpen skills for risk identification, mitigation and response
Consider why QTLs and KRIs must line up and how QTL management can be more robust
Engage sites to respond to central monitoring outputs

Who Will Attend

WHO SHOULD ATTEND?

RBM/RBQM
Study Monitoring
Central Monitoring/Site Monitoring
Clinical Operations
Clinical Research
Clinical Quality
Clinical Quality Assurance
Clinical Compliance
Clinical Outsourcing
Data Management
Data Science
Global Clinical Trial Operations
Regulatory Affairs
Risk Evaluation

Connect with industry leaders, expand your network, and benefit from exclusive access to industry updates. Discover new opportunities in a seamless, interactive learning environment. Elevate your experience with us!

Thank You To Our Sponsors

Maximize your brand's impact and visibility by becoming a valued sponsor. Shape the future of life sciences, connect with other industry leaders, and showcase your commitment to innovation. Elevate your presence - sponsor this conference and be at the forefront of advancements in science and technology.